Peter Attia drops insulin theory as scrutiny grows
Oct 15, 2026Thursday, October 15, 2026Summary from 2 contributing podcasts.
- Attia now says keto’s weight-loss effect comes from easier calorie control, not insulin suppression.
- Kaveh Hoda’s critiques question the evidence and risks behind broader longevity medicine.
Peter Attia hasn’t abandoned prevention, but he has walked back a central claim about how ketogenic diets work. That shift, described on his podcast, has landed alongside a growing critique of longevity medicine: how much of its promise rests on evidence from people, rather than theory and animal studies?
On Oct 12, 2026, The Peter Attia Drive featured Attia revisiting his views on diet and fasting. He said keto can help people lose weight by making it easier to feel full and eat fewer calories - not by suppressing insulin on its own. A person can still gain weight on keto if they eat more energy than they use, he said. Attia now accepts different diets if they support calorie control and adequate protein.
He also described stepping back from prolonged fasts. Attia said the hoped-for cellular cleanup, called autophagy, cannot be reliably measured in people, while extended fasting costs muscle and can impair recovery. His former routine included quarterly fasts of seven to 10 days and monthly three-day fasts.
On Oct 13, Behind the Bastards began a broader challenge to the medical model Attia represents. Physician Kaveh Hoda argued that concierge care narrows access: a typical doctor may serve 2,000 to 3,000 patients, compared with about 300 for a concierge physician. Hoda also questioned longevity interventions that lack rigorous human-trial evidence.
By Oct 15, Behind the Bastards had turned to the possible harms of aggressive screening and off-label drugs. Hoda cited a UC Davis study in which the most satisfied patients had a 26 percent higher mortality risk than the least satisfied, and argued that extra tests can lead to unnecessary treatment. He said rapamycin has no Phase 3 trials validating its use for longevity in healthy adults.
The Peter Attia Drive presents a physician revising his own claims; Behind the Bastards argues that the larger wellness industry still asks patients to accept too much on too little evidence. These accounts don’t settle which longevity practices help. They do sharpen the question: what human evidence would justify the risks and costs?
Source Intelligence
- Deep dive into what was said in the episodes
Part Two: Peter Attia and the Cult of Longevity • Oct 15
- After McKinsey, Attia returned to public-facing medicine through talks, media, and the Nutrition Science Initiative; Kaveh says the role let Attia build a scientific profile without board certification, before opening his longevity clinic Early Medicine.
- Attia's clinic offered intensive testing and monitoring, including glucose monitors for non-diabetic patients, repeated lipid panels, VO2 max tests, MRI and DEXA scans, wearables, off-label drugs, and after-hours consultations; Kaveh estimates annual fees of $100,000 to $500,000.
- Kaveh argues that elite concierge clinics create a more unequal medical system: the care is inaccessible to most patients, may reset wealthy clients' expectations of ordinary doctors, and is unlikely to scale to the general population.
- Attia built a large audience through The Drive, celebrity appearances, and his book Outlive; Kaveh says the book's popularity helped make Attia a major wellness figure.
- Attia's Medicine 3.0 pitch emphasizes prevention, personalization, and data; Kaveh says Attia uses the claim that 90% of Americans have a metabolic-syndrome marker, although the clinical definition requires at least three markers and one abnormal result alone is less meaningful.
- Kaveh lists the five metabolic-syndrome markers as abdominal obesity, high triglycerides, low HDL, high blood pressure, and elevated fasting glucose; the condition raises risk of diabetes, coronary disease, and stroke, but he favors lifestyle changes before reflexive medication.
- Kaveh questions Attia's routine advanced cardiac testing, including APOB, LP(a), CRP, calcium scoring, and coronary CT, because some tests have not been shown to improve outcomes and can trigger radiation exposure and further procedures; he says each test should change management to justify its use.
- Kaveh supports colorectal screening but says average-risk patients should start at 45, while Attia pushes for 40; younger-onset cases are increasing, but Kaveh says absolute risk remains low and earlier testing should depend on risk factors or symptoms.
- Kaveh cites a 2012 UC Davis study in which the most satisfied patients spent more on healthcare, had more hospital admissions, and faced higher mortality; a 2019 Cochrane review also found risks from overdiagnosis and unnecessary treatment.
- Kaveh says continuous glucose monitors have no established benefit for people without diabetes and can cause anxiety, restrictive eating, and unnecessary expense; Attia advertised for Dexcom, and the company said his advisory role ended in 2021.
- Kaveh says Attia overextends limited evidence on zone-two exercise, cancer, and diet: glucose use by cancer cells does not establish that avoiding sugar slows cancer, and evidence does not support ketogenic diets, prolonged fasting, or calorie restriction as longevity treatments.
- Attia prescribes rapamycin off-label for longevity despite the absence of phase-three trials; Kaveh says animal evidence remains preliminary, human evidence is limited, and immunosuppression can raise infection, lymphoma, and metabolic risks.
- Kaveh says Attia's authority comes partly from speaking fluently about data while operating beyond his formal training in cardiovascular disease, endocrinology, neurodegeneration, and nutrition; Kaveh sees this as science-washing that can lend credibility to MAHA and anti-vaccine figures.
- Kaveh says Attia's critique of Medicine 2.0 understates gains from vaccines, antibiotics, and conventional research; Attia's own praise of immunotherapy relies on advances produced by that system, while diseases such as cancer and Alzheimer's affect more people because public health has extended lifespans.
- Kaveh frames Attia as a warning about doctors serving wealthy, famous patients: the desire to please powerful people can push clinicians beyond appropriate care, while influence and a polished public persona can outrun evidence and medical guardrails.
Also discussed on this episode: (8)
Health (3)
- Kaveh says Peter Attia spent two years at McKinsey after leaving residency, working on corporate risk rather than medical projects; Attia later described the job as a period of systems-level thinking.
- McKinsey advised Purdue Pharma on growing OxyContin sales, including targeting high-volume prescribers and promoting higher-dose pills; Kaveh says the firm also helped counter public-health warnings and knowingly misled the FDA through overlapping assignments.
- Kaveh says Attia's book recounts that he stayed in New York while his one-month-old son was hospitalized after nearly dying, despite his wife's requests that he return; Epstein emails show Attia arranging to meet him during that same ICU period.
Enterprise (1)
- Kaveh says McKinsey accepted responsibility for a misdemeanor charge tied to misbranding prescription drugs, while senior partner Martin Elling faced felony obstruction charges; the firm also cut its global workforce and drew criticism over Enron and work with authoritarian governments.
Society (2)
- Attia met Jeffrey Epstein in 2014, years after Epstein's 2008 conviction, and exchanged medical advice, referrals, and business help with him; Kaveh says Attia met Epstein about 10 times, stayed in a New York apartment, and expressed interest in visiting the island and Zorro Ranch, with no evidence he went to the ranch.
- Epstein introduced Attia to a foreign-born model who was later identified as one of Epstein's victims; Attia sought Epstein's help hiring her for his clinic, while emails cited by Kaveh indicate visa issues prevented the hire.
Longevity (1)
- Emails show Attia discussing sex and longevity with Epstein, including a 2016 offer to add years to Epstein's life for more sex; Attia also wrote that he could not tell anyone about Epstein's life, while later saying he never witnessed illegal behavior or saw anyone who appeared underage.
Media (1)
- After Epstein-file revelations, Attia left a CBS contributor role and parted ways with David and AG1; Kaveh says wearable company Oura also distanced itself from Attia, who is now suing the company.
Part One: Peter Attia and the Cult of Longevity • Oct 13
- Dr. Kaveh Hoda describes longevity medicine as a proactive model aimed at extending healthspan through geroscience. However, its top tier relies on experimental drugs that currently lack robust trial evidence in humans.
- Dr. Kaveh Hoda notes that concierge medicine accelerates healthcare collapse by shrinking physician patient loads from thousands down to a few hundred. This dynamic restricts access almost exclusively to wealthy clients.
Also discussed on this episode: (6)
Health (5)
- Dr. Kaveh Hoda cites medical research showing that patient outcomes during inpatient hospitalizations are better or equal when treated by female physicians compared to male physicians.
- Peter Attia was born in Toronto in 1973 to Egyptian parents. Before attending Stanford Medical School, Attia studied mechanical engineering and applied mathematics at Queen's University while competing in high-intensity endurance sports.
- During his general surgery residency at Johns Hopkins, Peter Attia created an unapproved Excel model to alter dosing schedules for the high-risk antibiotic gentamicin. Attia administered the drug without attending or pharmacy approval.
- Peter Attia abandoned his surgical residency in his fifth year, telling podcast host Jocko Willink that he resented the lack of meritocracy and standardized resident pay. Attia subsequently joined McKinsey & Company as a consultant.
- Dr. Kaveh Hoda argues that ignoring small-scale wellness quackery and unproven medical claims gradually degrades public scientific literacy. This passive acceptance ultimately undermines trust in critical public health measures like vaccination.
Labor (1)
- Dr. Kaveh Hoda explains that medical residencies previously exceeded 80 hours per week before labor regulations instituted an 80-hour work limit, though older practitioners often considered the restriction overly lenient.
#411 ‒ AMA #90: Strong convictions, loosely held: how Peter's views on fasting, keto, metformin, rapamycin, whole-body MRI, and exercise have changed • Oct 12
- Attia adopted the phrase strong convictions loosely held from a hedge fund manager to describe updating health theses when contradictory data emerges. Attia notes scientists must prioritize reducing uncertainty over defending original claims.
- Attia states that publishing identical medical guidance a decade after writing his book would indicate either rigid personal thinking or a complete lack of scientific progress.
- Attia updates his clinical views through a combination of evolving scientific literature, deep-dive discussions with expert podcast guests, and direct clinical observations from patient outcomes.
- Attia adhered to a strict ketogenic diet for 3 years, averaging morning fasting beta-hydroxybutyrate levels between 1.8 and 2.0 millimoles. Attia eventually abandoned the diet due to lifestyle restrictions rather than health concerns.
- Attia previously attributed ketogenic diet efficacy to insulin suppression under the carbohydrate-insulin model. Attia now believes ketogenic diets work primarily by helping patients naturally manage total energy intake through satiety.
- Attia asserts that metabolic dysfunction, visceral fat accumulation, and impaired insulin sensitivity stem from energy imbalances rather than hyperinsulinemia. Patients on ketogenic diets can still gain weight if maintaining an energy surplus.
- Attia remains agnostic on specific dietary structures as long as foundational metabolic targets are met. Attia requires patients to consume at least 1.4 grams of protein per kilogram of body weight daily.
- Attia previously conducted quarterly fasts of 7 to 10 days alongside monthly 3-day fasts to induce cellular autophagy. Attia undertook these protocols for longevity benefits rather than weight loss.
- Autophagy functions as an analog cellular recycling process where nutrient deprivation forces cells to degrade damaged organelles and pre-senescent structures. Attia highlights preclinical data showing significant autophagy acceleration requires roughly 3 days of fasting.